Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 5Cholangiocarcinoma 4Stomach Neoplasms 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Ovarian Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1

Interventions

pembrolizumab 14Paclitaxel 14Carboplatin 12Bevacizumab 7Specimen Handling 6Cisplatin 6olaparib 5Taxes 5Fulvestrant 5Nivolumab 4Megestrol Acetate 4Magnetic Resonance Spectroscopy 4Doxorubicin 4Biopsy 4palbociclib 3durvalumab 3Oxaliplatin 3Leucovorin 3Letrozole 3Immunoglobulin G 3Gemcitabine 3Fluorouracil 3Docetaxel 3Disulfides 3trastuzumab deruxtecan 2ribociclib 2pertuzumab 2lenvatinib 2ipatasertib 2dostarlimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Folfox protocol × 30 days × Clear all
NCT06840886 2026-05-14

A Study of PHST001 in Advanced Solid Tumors

Pheast Therapeutics

Phase 1 Recruiting
272 enrolled
CNSGastrointestinalGynecologic

Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡